Recent Quotes (30 days)

You have no recent quotes
chg | %

Cipher Pharmaceuticals Inc  

(Public, TSE:CPH)   Watch this stock  
Find more results for TSE:DND
5.05
0.00 (0.00%)
Delayed:   3:59PM EDT
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 3.50 - 6.00
Open     -
Vol / Avg. 0.00/11,212.00
Mkt cap 134.14M
P/E     -
Div/yield     -
EPS -1.42
Shares 26.62M
Beta 1.36
Inst. own     -
Aug 11, 2017
Q2 2017 Cipher Pharmaceuticals Inc Earnings Call - Webcast
  

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 44.75% -96.09%
Operating margin 64.40% -78.13%
EBITD margin - 4.79%
Return on average assets 26.78% -41.86%
Return on average equity 113.74% -108.34%
Employees 80 -
CDP Score - -

Address

2345 Argentia Rd Suite 100A
MISSISSAUGA, ON L5N 8K4
Canada
+1-905-6025840 (Phone)
+1-905-6020628 (Fax)

Website links

Description

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.

Officers and directors

John D. Mull M.D. Chairman of the Board
Age: 83
Robert D. Tessarolo President, Chief Executive Officer
Stephen L. Lemieux CPA Chief Financial Officer, Secretary
Ralph Bohrer President and General Manager of US Business
Age: 54
Joan Chypyha President, General Manager - Canada
Joseph Pecora President and General Manager - USA
Lorne Markowitz Vice President of Sales and Marketing
Linda Melanie Angaritis Vice President - Global Regulatory Compliance and Quality
Louise Blythe Vice President - Regulatory Affairs
Lynne Cheryl Bulger Vice President - Medical and Clinical Affairs